DEXAMETHASONE TABLE

The Defense Logistics Agency awarded a delivery order under contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC, CAGE 1UNB0, for the supply of five bottles of DEXAMETHASONE TABLETS, identified by NSN 6505012525602 and NDC 00054-4184-25, with a total contract value of $313.95. The order was issued on July 14, 2026, with a required delivery date of July 29, 2026, to Fort Lewis, WA, under FOB destination terms where the contractor assumes all freight costs and risks until delivery. The awardee has self-certified as a Small Business, Small Disadvantaged Business, and Women-Owned Small Business, triggering applicable federal reporting and verification obligations under FAR 19.14 and 19.15. Delivery must be shipped via traceable means with no use of parcel post, and all packaging must bear the contract number, delivery order number, and Traceable Control Number W91M1Z61190168 to ensure accountability within the DoD logistics system. Inspection and acceptance occur at the destination by the government, with no variance allowed in quantity and medical substitution permitted. Payment will be processed through the Defense Finance and Accounting Service in Columbus, OH, using a voucher-based system tied to delivery order and stock record numbers. The contracting officer is Lisa Quinn, reachable via email, and no Contracting Officer Representative is named. While the order references compliance with the underlying basic contract and includes labeling and traceability mandates, explicit FAR clauses, MIL-STD specifications, barcoding standards, packaging materials, or preservation methods are not detailed in the documentation. The award was made without competition under a pre-existing IDIQ vehicle, with no evaluation factors, options, or amendment history provided.